<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DD1F1403-9928-4563-8E48-326ACF87C706"><gtr:id>DD1F1403-9928-4563-8E48-326ACF87C706</gtr:id><gtr:name>University Hospital of Wales</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:department>School of Medicine</gtr:department><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DD1F1403-9928-4563-8E48-326ACF87C706"><gtr:id>DD1F1403-9928-4563-8E48-326ACF87C706</gtr:id><gtr:name>University Hospital of Wales</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/C7C0FC1F-2464-4404-9921-CAFD2EB08C64"><gtr:id>C7C0FC1F-2464-4404-9921-CAFD2EB08C64</gtr:id><gtr:firstName>Eddie</gtr:firstName><gtr:otherNames>Chung</gtr:otherNames><gtr:surname>Wang</gtr:surname><gtr:orcidId>0000-0002-2243-4964</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/A56659BA-683E-45AE-AB1C-DA0690F1DA7D"><gtr:id>A56659BA-683E-45AE-AB1C-DA0690F1DA7D</gtr:id><gtr:firstName>Awen</gtr:firstName><gtr:surname>Gallimore</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0500617"><gtr:id>8A9613E7-D210-440B-BEAC-A731A571551E</gtr:id><gtr:title>Cellular and Viral Immunology Resource at the Wales College of Medicine, Cardiff University</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0500617</gtr:grantReference><gtr:abstractText>Research in general is very labour intensive, often requiring large quantities of reagents for use in experiments. Thus, a lot of time and effort is required just for reagent generation, even before any experiments can be carried out. The idea of this proposal is to fund a facility that specializes in large-scale reagent generation (including antibodies, soluble proteins, cell lines and viruses), which can then support the research of multiple projects and collaborations. In so doing, it facilitates all of the studies, allowing more time for the researchers to carry out actual experiments rather than spending inordinate amounts of time generating reagents. In addition, it brings together researchers from different backgrounds with different expertise, allowing interaction and complimentation to enhance the research. Finally, such a facility would provide a bank of resources that can then be used whenever needed in the future. In this way, it will enhance the productivity and progress of immunological research at the Wales College of Medicine, as well as research associated with it nationally and internationally. This research ranges from understanding the basic mechanisms that control inflammation and immunity (to viruses, cancers or self ), to studies investigating arthritis and the way that disease-causing pathogens such as persistent viruses impact on the immune response. The results of this research will be presented at conferences and to wider audiences as it advances.</gtr:abstractText><gtr:technicalSummary>This proposal aims to provide salary and consumables for a named technician to continue supporting the research of the lead applicant and the co-applicant through the continued running of a tissue culture resource. The lead applicant, Dr Eddie Wang, holds an MRC CEG to study the function of death receptor 3, while the co-applicant, Dr Awen Gallimore, holds an MRC Senior Fellowship to investigate the role of regulatory T cells in a number of disease models. The grant holders already collaborate on research into melanocyte antigens, influenza and lymphocyte choriomeningitis virus (LCMV). These studies require intensive tissue culture, including: screening and storage of cell lines; purification of soluble proteins; production of titred virus stocks and; generation of hybridomas for antibody production. The grant holders also have collaborations with other groups within an existing MRC-COGG that currently provides essential tissue culture support via a facility run by the named technician. This COGG will expire in April 2006. The Collaboration Grant will extend this support for the full duration of the MRC CEG and Senior Fellowship.</gtr:technicalSummary><gtr:fund><gtr:end>2010-01-22</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-04-23</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>188883</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University Hospital of Wales</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Medical Microbiology</gtr:department><gtr:description>HCMVA</gtr:description><gtr:id>295EB135-C0CF-4D86-A79E-40DB0DC9783D</gtr:id><gtr:impact>Publications - PMID: 17522202, 17372005, 17374753, 18287244 Grants - MRC project grant awarded in 2007</gtr:impact><gtr:outcomeId>F10E7FFC678-1</gtr:outcomeId><gtr:partnerContribution>Reagents and intellectual input</gtr:partnerContribution><gtr:piContribution>Reagents and intellectual input</gtr:piContribution><gtr:sector>Hospitals</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University Hospital of Wales</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Medical Microbiology</gtr:department><gtr:description>HCMVB</gtr:description><gtr:id>611B39AE-0A6A-4A4A-BE90-6DB02E38532C</gtr:id><gtr:impact>Publications - PMID: 18383036, 17522202, 17372005, 17374753, 18287244 Grants - MRC project grant awarded in 2007</gtr:impact><gtr:outcomeId>48D5221F439-1</gtr:outcomeId><gtr:partnerContribution>Reagents and intellectual input</gtr:partnerContribution><gtr:piContribution>Reagents and intellectual input</gtr:piContribution><gtr:sector>Hospitals</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University Hospital of Wales</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Medical Biochemistry and Immunology</gtr:department><gtr:description>Complement</gtr:description><gtr:id>562E9E1A-BB8F-41EA-A086-9F80C3A49C43</gtr:id><gtr:impact>Publication - PMID: 16493049</gtr:impact><gtr:outcomeId>5C69316DF7F-1</gtr:outcomeId><gtr:partnerContribution>Reagents and intellectual input</gtr:partnerContribution><gtr:piContribution>Intellectual input</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Birmingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Birmingham Cancer Research UK Centre</gtr:department><gtr:description>EBV</gtr:description><gtr:id>0CF0FBD0-B674-4800-934A-973EF4204768</gtr:id><gtr:impact>Publication - PMID: 17079298</gtr:impact><gtr:outcomeId>D11542E04D1-1</gtr:outcomeId><gtr:partnerContribution>Reagents and intellectual input</gtr:partnerContribution><gtr:piContribution>Reagents and intellectual input</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University Hospital of Wales</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Medical Biochemistry and Immunology</gtr:department><gtr:description>MCMV</gtr:description><gtr:id>BA40EC53-F03D-4C86-AC21-1A00CF25B45A</gtr:id><gtr:impact>Grants - MRC project grant awarded in 2009</gtr:impact><gtr:outcomeId>DABC85B1AB6-1</gtr:outcomeId><gtr:partnerContribution>Reagents and intellectual input</gtr:partnerContribution><gtr:piContribution>Staff, reagents and intellectual input</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cardiff University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Medicine</gtr:department><gtr:description>Arthritis</gtr:description><gtr:id>C58E2180-40C5-44AB-9047-A1C633CC3E29</gtr:id><gtr:impact>Publications - PMID: 18824582 Grants - ARC PhD studentship awarded in 2008</gtr:impact><gtr:outcomeId>E93DC798468-1</gtr:outcomeId><gtr:partnerContribution>Reagents and intellectual input</gtr:partnerContribution><gtr:piContribution>Reagents and intellectual input</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>97110</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC CASE Studentship (GSK)</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>99848AB3-D234-4DA1-9DB0-A3CF14775D15</gtr:id><gtr:outcomeId>186598CF1020</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>53000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhD Studentship</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>Cardiff University</gtr:fundingOrg><gtr:id>68F3A434-8746-4020-A738-5975372FB583</gtr:id><gtr:outcomeId>C60F28762570</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>534818</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Project Grant</gtr:description><gtr:end>2013-05-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>33B5D3DE-932F-4562-BB00-D9D1B5257B03</gtr:id><gtr:outcomeId>33FE3B52EE80</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>80530</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>ARC PhD Studentship</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>Arthritis Research UK</gtr:fundingOrg><gtr:id>8B61121A-CA53-4E12-81BF-2B90BDA06E94</gtr:id><gtr:outcomeId>FAA51EDD8F00</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>080F6C20-58F6-4122-9092-5F984DD0CBA7</gtr:id><gtr:title>Expression of glycosylphosphatidylinositol-anchored CD59 on target cells enhances human NK cell-mediated cytotoxicity.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/effa4fd57fc8e16f84492bc73bbf2c5f"><gtr:id>effa4fd57fc8e16f84492bc73bbf2c5f</gtr:id><gtr:otherNames>Omidvar N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>02DBF3C3FFC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AB2BE48F-7CEE-428F-8C45-05C8874EE233</gtr:id><gtr:title>Cytomegalovirus destruction of focal adhesions revealed in a high-throughput Western blot analysis of cellular protein expression.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3b6d1b84696df7259b815e773b8f7237"><gtr:id>3b6d1b84696df7259b815e773b8f7237</gtr:id><gtr:otherNames>Stanton RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>E80FD404D91</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A6B945F9-2FE0-4CF8-985C-13190711AE1B</gtr:id><gtr:title>Proliferation and interleukin 5 production by CD8hi CD57+ T cells.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/66afbdac5bfe2ab6ce81d3eb7c80f079"><gtr:id>66afbdac5bfe2ab6ce81d3eb7c80f079</gtr:id><gtr:otherNames>Chong LK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>CBD4417476A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6B48ABBF-F492-453B-ADFB-867C319B09DF</gtr:id><gtr:title>Age-dependent maintenance of motor control and corticostriatal innervation by death receptor 3.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf565f746b8db763e1aa7c73394b8ee2"><gtr:id>cf565f746b8db763e1aa7c73394b8ee2</gtr:id><gtr:otherNames>Twohig JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>e5pkj79xqKs</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>90101AD3-3C6E-4438-83F7-8E44BEAA99DF</gtr:id><gtr:title>Adenovirus E3/19K promotes evasion of NK cell recognition by intracellular sequestration of the NKG2D ligands major histocompatibility complex class I chain-related proteins A and B.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c345338015db5b28ee186446ac270dc0"><gtr:id>c345338015db5b28ee186446ac270dc0</gtr:id><gtr:otherNames>McSharry BP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>9413B55DF31</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FB0A7B84-4682-4B89-82A8-1CF6D5E64057</gtr:id><gtr:title>Novel role of regulatory T cells in limiting early neutrophil responses in skin.</gtr:title><gtr:parentPublicationTitle>Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d27c01ff007a6bb9440f557dfd2e7065"><gtr:id>d27c01ff007a6bb9440f557dfd2e7065</gtr:id><gtr:otherNames>Richards H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0019-2805</gtr:issn><gtr:outcomeId>pm_13467_27_20722759</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F061D561-DCCC-4832-A0BA-38F5FB6EB35D</gtr:id><gtr:title>A high-efficiency system of natural killer cell cloning.</gtr:title><gtr:parentPublicationTitle>Journal of immunological methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a190ea1fc342ec2d7bdfd8fbdc7115c7"><gtr:id>a190ea1fc342ec2d7bdfd8fbdc7115c7</gtr:id><gtr:otherNames>Morris RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0022-1759</gtr:issn><gtr:outcomeId>E802C4A686F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5F46F7DD-7EB2-4C03-9ED1-0EB014980055</gtr:id><gtr:title>TL1A both promotes and protects from renal inflammation and injury.</gtr:title><gtr:parentPublicationTitle>Journal of the American Society of Nephrology : JASN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b998be4188d5c8d563cef6a1110d03e9"><gtr:id>b998be4188d5c8d563cef6a1110d03e9</gtr:id><gtr:otherNames>Al-Lamki RS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1046-6673</gtr:issn><gtr:outcomeId>2168E1AB5BD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>71F908C8-F7EB-4DB0-AA89-C14BC1B61B75</gtr:id><gtr:title>The human cytomegalovirus MHC class I homolog UL18 inhibits LIR-1+ but activates LIR-1- NK cells.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/58e38151138fdd15af992c15175ac172"><gtr:id>58e38151138fdd15af992c15175ac172</gtr:id><gtr:otherNames>Prod'homme V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>C52671F8731</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FC7545C3-19DC-4941-9C23-CC368F80821D</gtr:id><gtr:title>The TNF-family receptor DR3 is essential for diverse T cell-mediated inflammatory diseases.</gtr:title><gtr:parentPublicationTitle>Immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2a6c6144d58e1219cffe64c94ca387bd"><gtr:id>2a6c6144d58e1219cffe64c94ca387bd</gtr:id><gtr:otherNames>Meylan F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1074-7613</gtr:issn><gtr:outcomeId>98C98121ED7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7B199C29-FE26-4002-A11F-F3AD0D45B339</gtr:id><gtr:title>Downregulation of natural killer cell-activating ligand CD155 by human cytomegalovirus UL141.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4ab6b817c8e9b654853c81fa652b9c62"><gtr:id>4ab6b817c8e9b654853c81fa652b9c62</gtr:id><gtr:otherNames>Tomasec P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>553325B8A70</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D3935B31-5BAB-4CC6-A541-864A67710A29</gtr:id><gtr:title>Reduced tumor necrosis factor signaling in primary human fibroblasts containing a tumor necrosis factor receptor superfamily 1A mutant.</gtr:title><gtr:parentPublicationTitle>Arthritis and rheumatism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/27f386b857f5e32f6b38b6bf2aa25fa1"><gtr:id>27f386b857f5e32f6b38b6bf2aa25fa1</gtr:id><gtr:otherNames>Siebert S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0004-3591</gtr:issn><gtr:outcomeId>1168FA9FC9C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>79C69429-37FD-40CB-8F92-157456384354</gtr:id><gtr:title>CD4+CD25+FOXP3+ regulatory T cells suppress anti-tumor immune responses in patients with colorectal cancer.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7c50fdf20c74fb7c3df0baa3dd44568e"><gtr:id>7c50fdf20c74fb7c3df0baa3dd44568e</gtr:id><gtr:otherNames>Clarke SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>B27416AAC03</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4E10D982-5ED3-48F1-95C9-91A6AEE00229</gtr:id><gtr:title>The Death Receptor 3-TNF-like protein 1A pathway drives adverse bone pathology in inflammatory arthritis.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6cfc971aa261f45e03d8f66a9f431d6d"><gtr:id>6cfc971aa261f45e03d8f66a9f431d6d</gtr:id><gtr:otherNames>Bull MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>0F39C2FA06E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1542C688-428E-49FC-8BF4-D95A2A1FC5DA</gtr:id><gtr:title>The switch from latent to productive infection in epstein-barr virus-infected B cells is associated with sensitization to NK cell killing.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/932ff82d19294875266fa547cd2d6b84"><gtr:id>932ff82d19294875266fa547cd2d6b84</gtr:id><gtr:otherNames>Pappworth IY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>6C5BB79485E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B707DF13-E895-4E57-9FB9-DFBC80A2E6E4</gtr:id><gtr:title>Adenovirus vector delivery stimulates natural killer cell recognition.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4ab6b817c8e9b654853c81fa652b9c62"><gtr:id>4ab6b817c8e9b654853c81fa652b9c62</gtr:id><gtr:otherNames>Tomasec P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>47CFD795B39</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF55C165-7551-4D22-8ED0-DF7312C89AC8</gtr:id><gtr:title>Defective B cell ontogeny and humoral immune response in mice prematurely expressing human complement receptor 2 (CR2, CD21) is similar to that seen in aging wild type mice.</gtr:title><gtr:parentPublicationTitle>Molecular immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf565f746b8db763e1aa7c73394b8ee2"><gtr:id>cf565f746b8db763e1aa7c73394b8ee2</gtr:id><gtr:otherNames>Twohig JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0161-5890</gtr:issn><gtr:outcomeId>F65D5707177</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BB676A77-8356-4151-A5AF-4D7EDB2B9A95</gtr:id><gtr:title>The impact of regulatory T cells on carcinogen-induced sarcogenesis.</gtr:title><gtr:parentPublicationTitle>British journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e91fffe206cb1e737057bda6fec65cc"><gtr:id>8e91fffe206cb1e737057bda6fec65cc</gtr:id><gtr:otherNames>Betts G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0007-0920</gtr:issn><gtr:outcomeId>D26B4C8C025</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6DB997B4-D2AC-4D6F-A468-8D45C1BEC35E</gtr:id><gtr:title>CD62L (L-selectin) down-regulation does not affect memory T cell distribution but failure to shed compromises anti-viral immunity.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d27c01ff007a6bb9440f557dfd2e7065"><gtr:id>d27c01ff007a6bb9440f557dfd2e7065</gtr:id><gtr:otherNames>Richards H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>9BF8294F7C9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>53693F4A-A5B4-46CE-A7D5-3A5DB2D803AC</gtr:id><gtr:title>Modulation of natural killer cells by human cytomegalovirus.</gtr:title><gtr:parentPublicationTitle>Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d8a2735a3ab0c4d75ed431e7759769ce"><gtr:id>d8a2735a3ab0c4d75ed431e7759769ce</gtr:id><gtr:otherNames>Wilkinson GW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1386-6532</gtr:issn><gtr:outcomeId>6158A448004</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D36CEFEC-A741-4894-BF48-CB7D1E7C10EE</gtr:id><gtr:title>The inhibitor of cyclin-dependent kinases, olomoucine II, exhibits potent antiviral properties.</gtr:title><gtr:parentPublicationTitle>Antiviral chemistry &amp; chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4d70f79ddb10659f4b9e446ebaf2d628"><gtr:id>4d70f79ddb10659f4b9e446ebaf2d628</gtr:id><gtr:otherNames>Holcakova J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0956-3202</gtr:issn><gtr:outcomeId>rC4J1sDvkyT</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5EECB4E6-8526-4F30-A7CB-3841F0ACF5D1</gtr:id><gtr:title>Potent T cell agonism mediated by a very rapid TCR/pMHC interaction.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9633af825b05487fae52582801ead272"><gtr:id>9633af825b05487fae52582801ead272</gtr:id><gtr:otherNames>Boulter JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>BE76844CE43</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>95273DBE-4507-435D-9F1A-8867EA8B3E88</gtr:id><gtr:title>CD59a deficiency exacerbates influenza-induced lung inflammation through complement-dependent and -independent mechanisms.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f6e620f85cf08dfc7d4e9d2da9a94ac0"><gtr:id>f6e620f85cf08dfc7d4e9d2da9a94ac0</gtr:id><gtr:otherNames>Longhi MP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>6CC5638F05F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>37D01272-94C5-4A66-B143-7AE8CB74A1B2</gtr:id><gtr:title>Characterization of a highly glycosylated form of the human cytomegalovirus HLA class I homologue gpUL18.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d2a785ff36a73dbabb9a12771c5e73e"><gtr:id>9d2a785ff36a73dbabb9a12771c5e73e</gtr:id><gtr:otherNames>Griffin C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>50D6D8447EB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B54730C6-A617-4B91-A13C-86B6B4FDFE92</gtr:id><gtr:title>Interleukin-6 is crucial for recall of influenza-specific memory CD4 T cells.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f6e620f85cf08dfc7d4e9d2da9a94ac0"><gtr:id>f6e620f85cf08dfc7d4e9d2da9a94ac0</gtr:id><gtr:otherNames>Longhi MP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>FEABCD71894</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0500617</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>34</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>93C4699B-9E5C-4982-9CCC-EFD5B9712D6E</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.6  Resources and infrastructure (aetiology)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>